$VPHM Company News Morgan Stanley drops Google from best

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2013 at 7:42 PM

$VPHM Company News

Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com

Biotech Stock Roundup: Vanda Soars, Sarepta Slumps - Analyst Blog 11:33 a.m. Today - Zacks.com
UPDATE: Stifel Downgrades ViroPharma Following News of Proposed Acquisition by Shire Pharmaceuticals 8:19 a.m. Nov. 19, 2013 - benzinga.com
Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Nov. 11, 2013 - TheStreet.com

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Nov. 11, 2013 - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Nov. 11, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NIDS Aims Global with CES 2027, Boosts Sensor Supply

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Context Labs Unveils AI Distillery for Enterprises

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Roof Flashing Insights with Expert Jeremiah Lightsey

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Navigating Underinsured Motorist Coverage Woes

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

Decoding Real Estate Value: A Market Insider's Take

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Yangtze River Culture Festival Spotlights Integration, Tradition

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...